DYAX CORP
S-1/A, EX-27.1, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: DYAX CORP, S-1/A, EX-23.3, 2000-08-14
Next: KAYE GROUP INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   12-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               DEC-31-1999             JUN-30-2000
<CASH>                                          16,726                  16,156
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    3,227                   3,662
<ALLOWANCES>                                     (129)                   (129)
<INVENTORY>                                      2,912                   2,655
<CURRENT-ASSETS>                                23,071                  23,146
<PP&E>                                           5,633                   6,865
<DEPRECIATION>                                 (2,924)                 (3,332)
<TOTAL-ASSETS>                                  29,608                  30,053
<CURRENT-LIABILITIES>                            7,792                  10,433
<BONDS>                                              0                       0
                                0                       0
                                     57,426                  57,426
<COMMON>                                            24                      25
<OTHER-SE>                                    (38,150)                (45,616)
<TOTAL-LIABILITY-AND-EQUITY>                    29,608                  30,053
<SALES>                                         16,833                  10,263
<TOTAL-REVENUES>                                16,833                  10,263
<CGS>                                            5,515                   3,071
<TOTAL-COSTS>                                   31,141                  19,306
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                  81                      94
<INCOME-PRETAX>                               (13,187)                 (8,725)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                           (13,187)                 (8,725)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                  (13,187)                 (8,725)
<EPS-BASIC>                                     (6.81)                  (3.74)
<EPS-DILUTED>                                   (6.81)                  (3.74)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission